Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy

Drug Discovery Today

Volumn 19, Issue 9, 2014, Pages 1387-1393

  Kwa, Faith A A ^a   Thrimawithana, Thilini R ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DNA DIRECTED DNA POLYMERASE GAMMA; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; ISOTRETINOIN; MINOCYCLINE; OXIDOREDUCTASE; SUPEROXIDE DISMUTASE;

AGE RELATED MACULAR DEGENERATION; ALTERNATIVE MEDICINE; APOPTOSIS; BLINDNESS; CHROMATIN; COMPLEMENT ACTIVATION; CPG ISLAND; DIABETIC RETINOPATHY; DNA METHYLATION; DRUG MECHANISM; DRUG SPECIFICITY; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENOTYPE; HISTONE MODIFICATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; ANIMAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; DRUG DESIGN; DRUG SCREENING; GENETIC EPIGENESIS; GENETICS; MACULAR DEGENERATION; MOLECULARLY TARGETED THERAPY; PROCEDURES;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIABETIC RETINOPATHY; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; EPIGENESIS, GENETIC; EPIGENOMICS; HUMANS; MACULAR DEGENERATION; MOLECULAR TARGETED THERAPY;

EID: 84907821462     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.03.026     Document Type: Review

References (67)

1. E.R. Gibney, and C.M. Nolan Epigenetics and gene expression Heredity 105 2010 4 13
2. P.M. Das, and R. Singal DNA methylation and cancer J. Clin. Oncol. 22 2004 4632 4642
3. R.M. Kohli, and Y. Zhang TET enzymes, TDG and the dynamics of DNA demethylation Nature 502 2013 472 479
4. M. Yoshida Histone deacetylase as a new target for cancer chemotherapy Cancer Chemother. Pharmacol. 48 2001 S20 S26
5. S. Timmermann Histone acetylation and diseases Cell. Mol. Life Sci. 58 2001 728 736
6. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
7. S. Ropero, and M. Esteller The role of histone deacetylases (HDACs) in human cancer Mol. Oncol. 1 2007 19 25
8. M.A. Halili Histone deacetylase inhibitors in inflammatory disease Curr. Top. Med. Chem. 9 2009 309 319
9. M. Katoh Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks Int. J. Mol. Med. 32 2013 763 767
10. D.F. Rosberger Diabetic retinopathy. current concepts and emerging therapy Endocrinol. Metab. Clin. N. Am. 42 2013 721 745
11. G. Donati Emerging therapies for neovascular age-related macular degeneration: state of the art Ophthalmologica 221 2007 366 377
12. T. Suuronen Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells Biochem. Biophys. Res. Commun. 357 2007 397 401
13. S. Bhattacharya Age-related susceptibility to apoptosis in human retinal pigment epithelial cells is triggered by disruption of p53-Mdm2 association Invest. Ophthalmol. Vis. Sci. 53 2012 8350 8366
14. S. Balaiya Hypoxia inititates sirtuin 1-mediated vascular endothelial growth factor activation in choroidal endothelial cells through hypoxia inducible factor-2 Mol. Vis. 18 2012 114 120
15. P.N. Baird, and L. Wei Age-related macular degeneration and DNA methylation Epigenomics 5 2013 239 241
16. L.M. Hjelmeland Dark matters in AMD genetics: epigenetics and stochasticity Invest. Ophthalmol. Vis. Sci. 52 2010 1622 1631
17. S.G. Jarrett Mitochondrial DNA damage and its potential role in retinal degeneration Progr. Retinal Eye Res. 27 2008 596 607
18. J.M. Seddon Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US twin study of age-related macular degeneration Arch. Ophthalmol. 124 2006 995 1001
19. K.J. Cruickshanks Sunlight and age-related macular degeneration: the Beaver Dam Eye Study Arch. Ophthalmol. 111 1993 514 518
20. J. Zhou Indirect antioxidant protection against photooxidative processes initiated in retinal pigment epithelial cells by a lipofuscin pigment Rejuvenation Res. 9 2006 256 263
21. A. Hunter DNA methylation is associated with altered gene expression in AMD Invest. Ophthalmol. Vis. Sci. 53 2012 2089 2105
22. J.P. Gnana-Prakasam Loss of Hfe to progression of tumour phenotype in primary retinal pigment epithelial cells Invest. Ophthalmol. Vis. Sci. 54 2013 63 71
23. J.M. Sedivy Aging by epigenetics: a consequence of chromatin damage? Exp. Cell Res. 314 2008 1909 1917
24. M.S. Kim Histone deacetylase induces angiogenesis by negative regulation of tumour suppressor genes Nat. Med. 7 2001 437 443
25. S. Wang Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7 Proc. Natl. Acad. Sci. U. S. A. 105 2008 7738 7743
26. S. He Epigenetic mechanisms in ocular disease Mol. Vis. 19 2013 665 674
27. L. Wei Hypomethylation of the IL17RC promoter associates with age-related macular degeneration Cell Rep. 2 2012 1151 1158
28. D.M. Hellebreker Angiostatic activity of DNA methyltransferase inhibitors Mol. Cancer Ther. 5 2006 467 475
29. F.A. Kwa Chromatin modifying agents: the cutting edge of anticancer therapy Drug Discov. Today 16 2011 543 547
30. F. Blanchard, and C. Chipoy Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov. Today 10 2005 197 204
31. K.A. Bode Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcriptor factor recruitment Immunology 122 2007 596 606
32. A. Nencioni Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity Clin. Cancer Res. 13 2007 3933 3941
33. C.E. Crosson Inhibition of histone deacetylase protects the retina from ischemic injury Invest. Ophthalmol. Vis. Sci. 51 2010 3639 3645
34. M. Michaelis Valproic acid inhibits angiogenesis in vitro and in vivo Mol. Pharmacol. 65 2004 520 527
35. I. Buysschaert Genetics, epigenetics and pharmaco-(epi)genomics in angiogenesis J. Cell. Mol. Med. 12 2008 2533 2551
36. L. Rossig Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis Circulat. Res. 91 2002 837 844
37. M. Tanito Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice Invest. Ophthalmol. Vis. Sci. 46 2005 979 987
38. Kilmko PG and Bingaman DP. Alcon Incorporated Histone deacetylase inhibitors for the treatment of ocular neovascular or edematous disorders and diseases. WO2004/043352
39. H. Uchida Vitamin A up-regulates the expression of thrombospondin-1 and pigment epithelial cells Exp. Eye Res. 80 2005 23 30
40. T.H. Tezel Retinal pigment epithelium rescues vascular endothelium from retinoic acid-induced apoptosis Invest. Ophthalmol. Vis. Sci. 47 2006 5075 5087
41. A. Cvekl, and K.P. Mitton Epigenetic regulatory mechanisms in vertebrate eye development and disease Heredity 105 2010 135 151
42. L.Z. Heng Diabetic retinopathy: pathogenesis, clinical grading, management and future developments Diabetic Med. 30 2013 640 650
43. J. Torres Genome wide association studies for diabetes: perspective on results and challenges Pediatr. Diabetes 14 2013 90 96
44. R.A. Kowluru Epigenetic modifications and diabetic retinopathy BioMed Res. Int. 2013 2013 635284
45. A. Syreeni Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes Diabetes 60 2011 3073 3080
46. R.A. Kowluru Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 47 2006 1594 1599
47. Q. Zhong, and R.A. Kowluru Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy Diabetes 60 2011 1304 1313
48. Q. Zhong, and R.A. Kowluru Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation Invest. Ophthalmol. Vis. Sci. 54 2013 244 250
49. Q. Zhong, and R.A. Kowluru Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon J. Cell. Biochem. 110 2010 1306 1313
50. C.S.R. Kadiyala Acetylation of retinal histones in diabetes increases inflammatory proteins: Effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC) J. Biol. Chem. 287 2012 25869 25880
51. R.A. Kowluru Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage Diabetes 60 2011 3023 3033
52. Q. Zhong, and R.A. Kowluru Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy Diabetes 62 2013 2559 2568
53. S. Tewari Damaged mitochondrial DNA replication system and the development of diabetic retinopathy Antioxid. Redox Signal. 17 2012 492 504
54. S. Tewari Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy Invest. Ophthalmol. Vis. Sci. 53 2012 4881 4888
55. X. Wang Histone deacetylases and their inhibitors: molecular mechanisms and therapeutic implications in diabetes mellitus Acta Pharm. Sin. B 2 2012 387 395
56. J. Fan Inhibition of HDAC2 protects the retina from ischemic injury Invest. Ophthalmol. Vis. Sci. 54 2013 4072 4080
57. Z. Zhang Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation Exp. Eye Res. 94 2012 98 108
58. L. Lopez Assessment of colour vision in epileptic patients exposed to single drug therapy Eur. Neurol. 41 1999 201 205
59. R. Sisk Valproic acid treatment may be harmful in non-dominant forms of retinitis pigmentosa Br. J. Ophthalmol. 96 2012 1154 1155
60. S. Bhalla Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid Br. J. Ophthalmol. 97 2013 895 899
61. L.L. Wang Elevated histone acetylations in Müller cell contribute to inflammation: a novel inhibitory effect of minocycline GLIA 60 2012 1896 1905
62. K. Balasubramanyam Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription J. Biol. Chem. 279 2004 51163 51171
63. S.K. Gupta Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms J. Ocul. Pharmacol. Ther. 27 2011 123 130
64. L.L. Wang Curcumin, a potential therapeutic candidate for retinal diseases Mol. Nutr. Food Res. 57 2013 1557 1568
65. R.A. Sharma Curcumin: the story so far Eur. J. Cancer 41 2005 1955 1968
66. F.G. Soufi Resveratrol improves diabetic retinopathy possibly through oxidative stress: nuclear factor κB-apoptosis pathway Pharmacol. Rep. 64 2012 1505 1514
67. G.J. Brewer Epigenetic oxidative redox Shift (EORS) theory of aging unifies the free radical and insulin signaling theories Exp. Gerontol. 45 2010 173 179